Nephros Announces Second Quarter 2020 Financial Results Conference Call
Nephros, a company specializing in water purification and pathogen detection systems, will release its second quarter 2020 financial results on August 5, 2020.
Rhea-AI Summary
Nephros, a company specializing in water purification and pathogen detection systems, will release its second quarter 2020 financial results on August 5, 2020. The management will host a conference call at 4:30 PM ET to discuss these results and provide a business overview. Interested parties can join by calling 1-844-808-7106 (domestic) or 1-412-317-5285 (international). A replay will be available until August 12, 2020.
Nephros’s products include ultrafilters for medical facilities and commercial filters aimed at improving water quality.
Positive
- None.
Negative
- None.
Details
News Market Reaction – NEPH
The recorded move for NEPH in the trading session of this news was +2.69%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SOUTH ORANGE, NJ, July 29, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells water purification products and pathogen detection systems to the medical and commercial markets, today announced that it will file its second quarter 2020 financial results on Wednesday, August 5, 2020 and will host a conference call that same day at 4:30 PM ET, during which management will discuss the company's financial results and provide a general business overview.
Participants may dial into the following number to access the call: 1-844-808-7106. International callers may use 1-412-317-5285. Please ask to be joined into the Nephros conference call. A replay of the call can be accessed until August 12, 2020 at 1-877-344-7529 or 1-412-317-0088 for international callers and entering replay access code: 10144283. An audio archive of the call will be available shortly after the call on the Nephros investor relations page at https://investors.nephros.com/events/.
About Nephros:
Nephros is a commercial-stage company that develops and markets high-performance water purification products and pathogen detection systems for medical and commercial markets.
Nephros ultrafilters are used in hospitals, medical clinics, and commercial facilities to retain bacteria and viruses from water, providing barriers that aid in infection control for showers, sinks, and ice machines. Nephros ultrafilters are also used in dialysis centers to aid in the removal of endotoxins and other biological contaminants from water and bicarbonate concentrate in hemodialysis machines.
Nephros pathogen detection systems, including the PluraPath™ and SequaPath™ systems, provide near-real time information on bacterial genera, waterborne bacteria, and viruses to medical and water safety professionals. These products integrate Nephros ultrafilters with DNA sequencing and quantitative polymerase chain reaction (qPCR) technology.
Nephros commercial filters, including AETHER™ brand filters, improve the taste and odor of water, and reduce scale build-up in downstream equipment. Nephros and AETHER™ products are used in the health care, food service, hospitality, and convenience store markets.
For more information about Nephros, please visit its website at www.nephros.com.
Investor Relations Contact:
Kirin Smith, President
PCG Advisory, Inc.
(646) 863-6519
ksmith@pcgadvisory.com
www.pcgadvisory.com
Media Contact:
Bill Douglass
Gotham Communications, LLC
(646) 504-0890
bill@gothamcomm.com
www.gothamcomm.com
Company Contact:
Andy Astor, COO & CFO
Nephros, Inc.
(201) 345-0824
andy@nephros.com
www.nephros.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.